Halozyme Therapeutics shares owned by Virtus Investment Advisers
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Virtus Investment Advisers
from 13F filings
Historical chart of Virtus Investment Advisers investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Virtus Investment Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $598k | 8.1k | 73.34 |
| 2025-06-30 | $424k | 8.1k | 52.02 |
| 2025-03-31 | $479k | 7.5k | 63.81 |
| 2024-12-31 | $105k | 2.2k | 47.81 |
| 2024-09-30 | $225k | 3.9k | 57.24 |
| 2024-06-30 | $206k | 3.9k | 52.36 |
| 2024-03-31 | $160k | 3.9k | 40.68 |
| 2023-12-31 | $317k | 8.6k | 36.96 |
| 2023-09-30 | $328k | 8.6k | 38.20 |
| 2023-06-30 | $309k | 8.6k | 36.07 |
| 2023-03-31 | $328k | 8.6k | 38.19 |
| 2022-12-31 | $462k | 8.1k | 56.90 |
| 2022-09-30 | $321k | 8.1k | 39.50 |
| 2017-12-31 | $0 | 19k | 0.00 |
More positions owned by Virtus Investment Advisers
View all positions for Virtus Investment Advisers